Xeris Biopharma Holdings Inc. buy SVB Leerink LLC
Start price
22.08.25
/
50%
€6.61
Target price
22.08.26
€7.75
Performance (%)
-9.61%
Price
11.12.25
€5.98
Summary
This prediction is currently active. With a performance of -9.61%, the BUY prediction by SVB_Leerink_LLC is trending in the wrong direction. This prediction currently runs until 22.08.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Xeris Biopharma Holdings Inc. | 3.463% | 3.463% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma (NASDAQ:XERS) had its price target raised by analysts at Leerink Partners from $7.00 to $9.00. They now have an "outperform" rating on the stock.
Ratings data for XERS provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€4.21
10.03.25
10.03.25
€5.52
10.03.26
10.03.26
42.06%
11.12.25
11.12.25
